Product Information
LAMOTRIGINE ODT 50 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.2710 per EA under NDC 43598055130. Its NADAC has been published 512 times since Dec 14, 2016.
FDA first approved this application on Jun 17, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598055130
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA206382FDA Approved
6/17/2016
TE Code
AB
On Market Since
6/17/2016
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ODT 50 MG TABLET has been published 512 times since Dec 14, 2016, and over the history we have for it it has declined 80.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2710 per EA |
|---|---|
| All-time high | $6.6982 (Feb 15, 2017) |
| All-time low | $1.2710 (Sep 23, 2026) |
| 52-week high | $1.7519 |
| 52-week low | $1.2710 |
| Median price | $4.3349 |
| Average price | $3.9802 |
| Largest weekly change | +55.3% (Mar 22, 2023) |
| Weeks tracked | 512 |
| Tracking since | Dec 14, 2016 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ODT 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ODT 50 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $1.2710 per EA (NDC 43598055130), effective Sep 30, 2026.
How has the price of LAMOTRIGINE ODT 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ODT 50 MG TABLET has declined 80.8%. It has been tracked across 512 weekly CMS publications since Dec 14, 2016.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ODT 50 MG TABLET?
Since Dec 14, 2016, the NADAC for LAMOTRIGINE ODT 50 MG TABLET has ranged from a low of $1.2710 (Sep 23, 2026) to a high of $6.6982 (Feb 15, 2017), with a median of $4.3349 per EA.
Are there cheaper alternatives to LAMOTRIGINE ODT 50 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE ER 50 MG TABLET, is $0.5941 per EA — about 53% below LAMOTRIGINE ODT 50 MG TABLET.
Who manufactures LAMOTRIGINE ODT 50 MG TABLET?
LAMOTRIGINE ODT 50 MG TABLET (NDC 43598055130) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.